Maryland AG Leads Bipartisan Push on Deceptive AI Weight-Loss Ads—Consumer Protection or Regulatory Creep?

A pharmacist in a CVS uniform introduces herself as Emily, holding a GLP-1 medication package, surrounded by shelves in a pharmacy.

By Michael Phillips | MDBayNews

A bipartisan coalition of 35 state attorneys general, led in part by Anthony G. Brown, is urging Meta to crack down on deceptive, AI-generated weight-loss advertising proliferating across Facebook and Instagram.

The December 17 letter—co-signed by attorneys general from states as ideologically diverse as Ohio, South Carolina, California, and New York—targets misleading ads promoting unregulated or compounded versions of popular GLP-1 weight-loss drugs. The coalition is not suing Meta (yet), but is demanding stronger enforcement of the company’s existing ad policies and the adoption of additional safeguards.

The move highlights a rare moment of bipartisan alignment on Big Tech accountability. It also raises familiar center-right questions about where consumer protection ends and regulatory overreach begins.


What the Attorneys General Are Complaining About

According to the coalition, thousands of weight-loss ads on Meta platforms use unlabeled AI-generated images, videos, and personas to make implausible—or outright impossible—claims.

Examples cited include:

  • AI-generated “models” claiming to lose over 200 pounds in a few weeks
  • Fake nurses, pharmacists, or law-enforcement officers endorsing products
  • Dramatic before-and-after images designed to exploit holiday and New Year body-image pressures
  • Little or no disclosure of side effects, medical risks, or regulatory status

Many of the ads promote compounded GLP-1 medications sold through telehealth services—products that are not FDA-approved for weight loss and are subject to fewer manufacturing and advertising controls.


What the Coalition Is Demanding

The attorneys general are urging Meta to take several voluntary steps, including:

  • Limiting weight-loss ads to FDA-approved prescription drugs
  • Requiring clear, prominent disclosures of risks and side effects
  • Prohibiting AI-generated models, testimonials, or “success stories” in weight-loss advertising
  • Improving AI detection and labeling tools
  • Redirecting users searching for weight-loss products to reputable medical resources instead of ads

Meta already claims to prohibit misleading health advertising, but the coalition argues enforcement is inconsistent and ineffective—particularly as AI tools make it easier to generate high-volume, low-accountability content.

As of this writing, Meta has not publicly responded.


Why This Resonates With Center-Right Voters

From a center-right perspective, the concern over deceptive health advertising is legitimate. Fraudulent medical claims harm consumers, undermine trust in legitimate healthcare, and exploit vulnerable people—especially when real health risks are concealed.

At the same time, conservatives are right to be cautious about the precedent being set.

This letter goes beyond asking Meta to enforce its own rules. It pushes the platform to:

  • Act as a gatekeeper for which drugs may be advertised
  • Ban entire categories of speech based on the use of AI
  • Steer users toward government-approved information sources

Those demands raise uncomfortable questions about speech, competition, and market access—particularly when compounded drugs are often cheaper alternatives during shortages of brand-name medications.

There is also an economic angle that deserves scrutiny: Meta profits heavily from these ads, and aggressive enforcement could disrupt a lucrative advertising category. Whether the platform prioritizes consumer safety over ad revenue remains an open question.


A Broader AI and Big Tech Test Case

This push fits into a growing pattern of bipartisan pressure on Big Tech over scams, misinformation, and AI-generated content. Weight-loss ads may be the immediate focus, but the implications extend far beyond health products.

If platforms are pressured to ban unlabeled AI content here, similar demands could follow in political advertising, financial services, or issue advocacy—areas where free-speech concerns are even more pronounced.

For now, the coalition is relying on voluntary compliance. But history suggests that if Meta does not act, investigations and enforcement actions may not be far behind.


Bottom Line

Maryland’s attorney general and his bipartisan counterparts are right to call out deceptive, AI-driven health scams that put consumers at risk. But the solution matters.

Strong enforcement against fraud is one thing. Pushing platforms toward broad content bans and quasi-regulatory roles is another. As AI reshapes advertising and speech online, this fight may become an early test of how far states—and tech companies—are willing to go in the name of consumer protection.

Concerned citizens should watch closely.


Keep MDBayNews Reporting Free

MDBayNews exists to help Marylanders understand decisions made by state and local leaders — especially when those decisions affect daily life, rights, and public services.

If this article helped clarify what’s happening or why it matters, reader support makes it possible to keep publishing clear, independent reporting like this.

👉 Support Local Journalism

Have a tip or documents to share?

We review submissions carefully and confidentially. Anonymous tips are welcome when appropriate.

 👉 Submit a Tip


Discover more from Maryland Bay News

Subscribe to get the latest posts sent to your email.

Leave a Reply

Discover more from Maryland Bay News

Subscribe now to keep reading and get access to the full archive.

Continue reading